Study S001372

A Master Protocol for a Randomized, Controlled, Clinical Platform Trial to Investigate the Efficacy and Safety of Interventions for Chronic Weight Management in Pediatric Participants With Obesity or Overweight

ClinicalTrials.gov record

Registration

Registration: NCT06672549
Acronym: ADVANCE
Study type: INTERVENTIONAL
Phase: PHASE3
Masking: NONE
Status: RECRUITING
Enrollment: 125
Start: 2024-11-18
Primary completion: 2027-02
Lead sponsor: Eli Lilly and Company
Conditions: Obesity; Overweight
Interventions: DRUG:Orforglipron; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: YES
Secondary identifiers: OTHER:J4M-MC-PWMP

Registered primary outcomes

Number of Participants Allocated to Each ISA [Baseline to Week 72]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.